Tessmer James F

VP, Finance & Accounting at LXRX

Sold, on record
$388k
Dollars the filings state
Form 4 sales
4
Latest Mar 15, 2021
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • LXRXLEXICON PHARMACEUTICALS, INC.VP, Finance & Accounting

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale LXRXUnusual
    May 23, 2016 2016

    Sold 6,000 shares at $13.00 ($78k)

    Tessmer James F, VP, Finance & Accounting

    Sold 27.3% of holdings ($285k position)15,946 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale LXRXPlan not stated
    Jun 6, 2016 +14 days

    Sold 1,500 shares at $15.00 ($23k)

    Tessmer James F, VP, Finance & Accounting

    Sold 8.6% of holdings ($262k position)15,946 shares leftFiling

  3. 3 Form 4 sale LXRXUnusual
    Jun 8, 2018 +732 days

    Sold 10,000 shares at $12.91 ($129k)

    Tessmer James F, VP, Finance & Accounting

    Sold 28.1% of holdings ($460k position)25,643 shares leftFirst sale on recordFiling

  4. 4 Form 4 sale LXRXPlan not stated
    Mar 15, 2021 +1011 days

    Sold 22,912 shares at $6.92 ($158k)

    Tessmer James F, VP, Finance & Accounting

    Sold 24.2% of holdings ($655k position)71,766 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Tessmer James F
Source
Mar 15, 2021Mar 16, 2021LXRXVP, Finance & AccountingForm 4 sale22,912$158k24.2%Plan not statedSEC
Jun 8, 2018Jun 12, 2018LXRXVP, Finance & AccountingForm 4 sale10,000$129k28.1%UnusualSEC
Jun 6, 2016Jun 8, 2016LXRXVP, Finance & AccountingForm 4 sale1,500$23k8.6%Plan not statedSEC
May 23, 2016May 23, 2016LXRXVP, Finance & AccountingForm 4 sale6,000$78k27.3%UnusualSEC